Jakafi 10 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FYBGN
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,116
Award facts
- Contract value 100% obligated
- $12,115.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $12,115.65 by the Defense Logistics Agency (DLA) on July 25, 2025. The contract calls for the delivery of Jakafi 10 mg tablets (60-count units), a prescription medication used in the treatment of myelofibrosis and polycythemia vera. This delivery order was issued without a set-aside designation, and the ultimate completion date is July 28, 2025. The place of performance is located in Park Ridge, Illinois, where the vendor maintains its headquarters and primary operations.
This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The IDC authorizes the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting the medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, with a robust portfolio of contract awards demonstrating consistent delivery of branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare sites nationally.
Quick answers
Who was awarded contract SPE2DB25FYBGN?
SPE2DB25FYBGN was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 25, 2025.
How much is contract SPE2DB25FYBGN worth?
The government has obligated $12,116 on SPE2DB25FYBGN.
Is contract SPE2DB25FYBGN an order under another contract?
Yes. SPE2DB25FYBGN is a delivery order under SPE2DB24D9313, an indefinite delivery contract.
Was contract SPE2DB25FYBGN competed?
The extent of competition for SPE2DB25FYBGN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award